File(s) not publicly available

Reason: No digital feature

A Response to: Letter to the Editor regarding Combination of Tocilizumab and Steroids to Improve 1 Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort

media

posted on 2021-04-14, 16:17 authored by Adis Journals on behalf of, Belén Ruiz-Antorán, Aránzazu Sancho-López, Ferrán Torres, Ana Fernández-Cruz

Article full text

There are currently no digital features for this article. For a full list of declarations, including funding and author disclosure statements, please see the full text online (see “read the peer-reviewed publication” opposite).

History

References

https://link.springer.com/article/10.1007/s40121-021-00444-4

Usage metrics

Read the peer-reviewed publication

A Response to: Letter to the Editor regarding Combination of Tocilizumab and Steroids to Improve 1 Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort

Infectious Diseases and Therapy

Keywords

Tocilizumab steroids COVID-19 SARS-CoV-2 mortality

Licence

CC BY-NC 4.0

File(s) not publicly available

A Response to: Letter to the Editor regarding Combination of Tocilizumab and Steroids to Improve 1 Mortality in Patients with Severe COVID-19 Infection: A Spanish, Multicenter, Cohort

History

References

Usage metrics

Read the peer-reviewed publication

Categories

Keywords

Licence

Exports